CDC Website CDC Website

To Join the NPIN community or

You are here

Persons with HIV/AIDS

Building and Improving Laboratory Capacity and Quality in the Democratic Republic of Congo (DRC) under the President's Emergency Plan for AIDS Relief (PEPFAR)

Access to quality assured diagnostics and laboratory services is critical to the effective diagnosis, treatment, and management of HIV and other HIV-related diseases, including TB. Achieving the UNAIDS 95-95-95 targets requires establishment and operationalization of laboratory and diagnostic networks.PEPFAR DRC supported laboratory and integrated diagnostic network strengthening efforts have led to improved access to the quality diagnostic and patient monitoring services. The data reports show improved viral load (VL) coverage from 27% to 56% in FY16 and FY17 and 75% suppression rate.

HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies of genotype/phenotype correlations in diverse subtypes, the relationship between drug resistance mutations present in minority variant viral populations and treatment outcomes, and on the reasons for the discordance between genotype and treatment success or failure. Laboratory evaluations of samples with clinical correlates in patients on recommended regimens are encouraged.

Supporting Laboratory Strengthening Activities and Partnerships for Countries Supported under the President's Emergency Plan for AIDS Relief (PEPFAR)

The purpose of this program build and strengthen in-country capacity for sustainable laboratory networks in PEPFAR-supported countries. The program will focus on: 1) workforce develop through enhanced in-service laboratory training and certification programs; 2) continuous quality improvement by strengthening the laboratory standards, policies and systems,; and; 3) increasing laboratory capacity to perform quality laboratory testing for Mycobacterium tuberculosis and other opportunistic infections.

AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)

This notice solicits applications for the Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF). The Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP) administers this program. ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures (for example, the provision of health insurance assistance).

Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program

This notice solicits applications for the Ryan White HIV/AIDS Program (RWHAP) Part A HIV Emergency Relief Grant Program. The purpose of this program is to provide direct financial assistance to an eligible metropolitan area (EMA) or a transitional grant area (TGA) that has been severely affected by the HIV epidemic. Grant funds assist eligible jurisdictions to develop or enhance access to a comprehensive continuum of high quality, community-based care for low-income people living with HIV (PLWH) through the provision of formula, supplemental, and Minority AIDS Initiative (MAI) funds.

Pages

Subscribe to RSS - Persons with HIV/AIDS